Your browser doesn't support javascript.
loading
Current perspectives on the management of patients with advanced RET-driven thyroid cancer in Europe.
Elisei, Rossella; Grande, Enrique; Kreissl, Michael C; Leboulleux, Sophie; Puri, Tarun; Fasnacht, Nicolas; Capdevila, Jaume.
Afiliación
  • Elisei R; Endocrine Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
  • Grande E; Medical Oncology Department, MD Anderson Cancer Center Madrid, Madrid, Spain.
  • Kreissl MC; Division of Nuclear Medicine, Department of Radiology and Nuclear Medicine, University Hospital of Magdeburg, Magdeburg, Germany.
  • Leboulleux S; Department of Endocrinology, Diabetes, Nutrition and Therapeutic Patient Education, Geneva University Hospitals, Geneva, Switzerland.
  • Puri T; Medical Affairs, Eli Lilly and Company, Indianapolis, IN, United States.
  • Fasnacht N; Medical Affairs, Eli Lilly and Company, Indianapolis, IN, United States.
  • Capdevila J; Medical Oncology Department, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology (VHIO), IOBTeknon, Barcelona, Spain.
Front Oncol ; 13: 1141314, 2023.
Article en En | MEDLINE | ID: mdl-37207147
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Front Oncol Año: 2023 Tipo del documento: Article País de afiliación: Italia
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Front Oncol Año: 2023 Tipo del documento: Article País de afiliación: Italia